| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Bellevue Global Life Science Investors LLC | 88% | $6,125,350 | 2,035,000 | Bellevue Capital Management LLC | 31 Dec 2024 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q1 | 0 | $0 | -$164,525 | $3.01 | 0 |
| 2024 Q4 | 14,270 | $164,525 | -$16,846,132 | $11.47 | 3 |
| 2024 Q3 | 1,556,780 | $16,926,881 | -$618,407 | $10.86 | 13 |
| 2024 Q2 | 1,616,626 | $17,396,991 | -$16,724,400 | $10.76 | 15 |
| 2024 Q1 | 3,181,220 | $33,914,154 | +$2,362,272 | $10.66 | 24 |
| 2023 Q4 | 2,969,727 | $31,153,416 | -$25,928,302 | $10.50 | 24 |
| 2023 Q3 | 5,614,300 | $58,401,725 | +$9,265,080 | $10.40 | 37 |
| 2023 Q2 | 4,729,193 | $48,522,742 | +$13,422,307 | $10.26 | 31 |
| 2023 Q1 | 3,224,140 | $32,560,178 | +$32,560,178 | $10.10 | 22 |